Penumbra share price today
(NASDAQ: PEN)

Name: Penumbra Share Price Today (NASDAQ: PEN) - Penumbra Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Penumbra share price is $273.78 & ₹23,679.23 as on 24 Jan 2025, 2.30 'hrs' IST

$273.78

▲

-2.06

(-0.75%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Penumbra share price in Dollar and Rupees. Guide to invest in Penumbra stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Penumbra, along with analyst recommendations, forecasts, and comprehensive financials.

Penumbra share price movements

Today's Low: $270.17
Today's High: $275.13
$273.78
1.32%
Downside
Day's Volatility :1.8%
Upside
0.49%
52 Weeks Low: $148.00
52 Weeks High: $277.89
$273.78
45.94%
Downside
52 Weeks Volatility :46.74%
Upside
1.48%

Penumbra Returns

Period	Penumbra Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	34.75%	-5.5%	0.0%
6 Months	54.59%	-4.3%	0.0%
1 Year	10.08%	1.6%	0.0%
3 Years	29.46%	9.8%	-11.0%

Penumbra Key Statistics

in dollars & INR

Previous Close	$275.84
Open	$275.65
Today's High	$275.13
Today's Low	$270.17
Market Capitalization	$10.3B
Today's Volume	$693.2K
52 Week High	$277.89
52 Week Low	$148.0
Revenue TTM	$1.2B
EBITDA	$102.5M
Earnings Per Share (EPS)	$0.89
PE Ratio	301.35
Profit Margin	2.97%
Quarterly Earnings Growth YOY	2.26%
Return On Equity TTM	3.13%

How to invest in Penumbra Stock (PEN) from India?

It is very easy for Indian residents to invest directly in Penumbra from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Penumbra stock in both Indian Rupees (INR) and US Dollars (USD). Search for Penumbra or PEN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Penumbra or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Penumbra shares which would translate to 0.003 fractional shares of Penumbra as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Penumbra, in just a few clicks!

Returns in Penumbra for Indian investors in Rupees

Investment Value

₹1,00,000

Penumbra investment value today

Current value as on today

₹1,13,309

Returns

₹13,309

(+13.31%)

Returns from Penumbra Stock

₹9,254 (+9.25%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Penumbra

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Penumbra on INDmoney from India has grown in the last 30 days as on Jan 24, 2025. 6% more investors are searching Penumbra in the last 30 days versus the previous period.

Global Institutional Holdings in Penumbra

FMR Inc
15.36%
BlackRock Inc
10.60%
Vanguard Group Inc
9.58%
T. Rowe Price Associates, Inc.
5.17%
Champlain Investment Partners, LLC
4.03%
State Street Corp
3.22%

Analyst Recommendation on Penumbra

Buy

70%Buy

30%Hold

0%Sell

Based on 20 Wall street analysts offering stock ratings for Penumbra(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Penumbra

What analysts predicted

Downside of 3.0%

Target:

$265.56

Current:

$273.78

Insights on Penumbra

Price Movement
In the last 6 months, PEN stock has moved up by 46.5%
Increasing Revenue
Revenue is up for the last 3 quarters, 278.65M → 301.03M (in $), with an average increase of 3.7% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -60.2M → 29.52M (in $), with an average increase of 303.9% per quarter
PEN vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 65.5% return, outperforming this stock by 56.5%
PEN vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 133.4% return, outperforming this stock by 107.0%
Price to Sales
ForPEN every $1 of sales, investors are willing to pay $9.2, whereas for Boston Scientific Corp., the investors are paying $9.3 for every $1 of sales.

Penumbra Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$444.9M	↑ 33.31%
Net Income	$6.6M	↑ 41.74%
Net Profit Margin	1.48%	↑ 0.08%

	FY19	Y/Y Change
Revenue	$547.4M	↑ 23.03%
Net Income	$48.5M	↑ 634.1%
Net Profit Margin	8.85%	↑ 7.37%

	FY20	Y/Y Change
Revenue	$560.4M	↑ 2.38%
Net Income	$-19.3M	↓ 139.74%
Net Profit Margin	-3.44%	↓ 12.29%

	FY21	Y/Y Change
Revenue	$747.6M	↑ 33.4%
Net Income	$2.6M	↓ 113.62%
Net Profit Margin	0.35%	↑ 3.79%

	FY22	Y/Y Change
Revenue	$847.1M	↑ 13.32%
Net Income	$-2.0M	↓ 176.32%
Net Profit Margin	-0.24%	↓ 0.59%

	FY23	Y/Y Change
Revenue	$1.1B	↑ 24.95%
Net Income	$91.0M	↓ 4643.16%
Net Profit Margin	8.59%	↑ 8.83%

	Q2 FY23	Q/Q Change
Revenue	$261.5M	↑ 8.33%
Net Income	$19.0M	↑ 121.44%
Net Profit Margin	7.25%	↑ 3.7%

	Q3 FY23	Q/Q Change
Revenue	$270.9M	↑ 3.61%
Net Income	$9.2M	↓ 51.4%
Net Profit Margin	3.4%	↓ 3.85%

	Q4 FY23	Q/Q Change
Revenue	$284.7M	↑ 5.07%
Net Income	$54.2M	↑ 488.43%
Net Profit Margin	19.05%	↑ 15.65%

	Q1 FY24	Q/Q Change
Revenue	$278.7M	↓ 2.12%
Net Income	$11.0M	↓ 79.71%
Net Profit Margin	3.95%	↓ 15.1%

	Q2 FY24	Q/Q Change
Revenue	$299.4M	↑ 7.45%
Net Income	$-60.2M	↓ 647.17%
Net Profit Margin	-20.11%	↓ 24.06%

	Q3 FY24	Q/Q Change
Revenue	$301.0M	↑ 0.55%
Net Income	$29.5M	↓ 149.05%
Net Profit Margin	9.81%	↑ 29.92%

	FY18	Y/Y Change
Profit	$292.5M	↑ 34.72%

	FY19	Y/Y Change
Profit	$372.0M	↑ 27.15%

	FY20	Y/Y Change
Profit	$338.2M	↓ 9.08%

	FY21	Y/Y Change
Profit	$475.4M	↑ 40.57%

	FY22	Y/Y Change
Profit	$535.2M	↑ 12.58%

	FY23	Y/Y Change
Profit	$682.6M	↑ 27.55%

	Q2 FY23	Q/Q Change
Profit	$166.9M	↑ 10.45%

	Q3 FY23	Q/Q Change
Profit	$177.7M	↑ 6.51%

	Q4 FY23	Q/Q Change
Profit	$187.0M	↑ 5.22%

	Q1 FY24	Q/Q Change
Profit	$178.7M	↓ 4.46%

	Q2 FY24	Q/Q Change
Profit	$160.3M	↓ 10.25%

	Q3 FY24	Q/Q Change
Profit	$200.3M	↑ 24.92%

	FY18	Y/Y Change
Operating Cash Flow	$28.8M	↑ 127.0%
Investing Cash Flow	$-385.0K	↓ 99.5%
Financing Cash Flow	$-9.8M	↓ 109.41%

	FY19	Y/Y Change
Operating Cash Flow	$26.7M	↓ 7.48%
Investing Cash Flow	$-12.7M	↑ 3201.56%
Financing Cash Flow	$-9.0M	↓ 8.72%

	FY20	Y/Y Change
Operating Cash Flow	$-33.2M	↓ 224.73%
Investing Cash Flow	$-104.1M	↑ 719.36%
Financing Cash Flow	$134.9M	↓ 1605.94%

	FY21	Y/Y Change
Operating Cash Flow	$9.5M	↓ 128.58%
Investing Cash Flow	$-21.7M	↓ 79.13%
Financing Cash Flow	$836.0K	↓ 99.38%

	FY22	Y/Y Change
Operating Cash Flow	$-55.7M	↓ 685.78%
Investing Cash Flow	$54.8M	↓ 352.08%
Financing Cash Flow	$11.6M	↑ 1290.19%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$17.1M	↑ 30.24%
Investing Cash Flow	$-6.7M	↓ 162.28%
Financing Cash Flow	$8.7M	↑ 531.83%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$30.8M	↑ 80.38%
Investing Cash Flow	$-40.4M	↑ 504.95%
Financing Cash Flow	$212.0K	↓ 97.56%

Penumbra Technicals Summary

Sell

Neutral

Buy

Penumbra is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Penumbra Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Penumbra Inc	14.68%	54.59%	10.08%	29.46%	59.96%
Medtronic Plc	7.73%	11.61%	2.39%	-15.68%	-26.33%
Edwards Lifesciences Corp.	-8.41%	10.69%	-6.13%	-36.94%	-9.52%
Boston Scientific Corp.	10.15%	33.89%	64.9%	135.97%	135.19%
Stryker Corporation	5.32%	17.73%	25.19%	56.65%	81.96%
Abbott Laboratories	2.63%	11.92%	4.74%	-4.45%	31.47%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Penumbra Inc	301.35	301.35	-62.27	2.78	0.03	0.03	NA	28.79
Medtronic Plc	27.03	27.03	1.5	5.46	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	26.66	26.66	6.43	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	83.4	83.4	1.79	2.46	0.09	0.05	NA	14.05
Stryker Corporation	42.47	42.47	2.68	12.06	0.19	0.07	0.01	52.86
Abbott Laboratories	34.45	34.45	2.2	4.67	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Penumbra Inc	Buy	$10.3B	59.96%	301.35	2.97%
Medtronic Plc	Buy	$113.3B	-26.33%	27.03	12.06%
Edwards Lifesciences Corp.	Buy	$40.7B	-9.52%	26.66	65.86%
Boston Scientific Corp.	Buy	$148.7B	135.19%	83.4	11.26%
Stryker Corporation	Buy	$150.9B	81.96%	42.47	16.34%
Abbott Laboratories	Buy	$202.6B	31.47%	34.45	13.99%

About Penumbra

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Organization	Penumbra
Employees	4200
CEO	Mr. Adam Elsesser J.D.
Industry	Health Technology

Management People of Penumbra

Name	Title
Mr. Adam Elsesser J.D.	Co-Founder, Chairman, President & CEO
Dr. Arani Bose M.D.	Co-Founder & Director
Ms. Maggie S. Yuen	Chief Financial Officer
Mr. Lambert Shiu	Chief Accounting Officer
Ms. Johanna Roberts J.D.	Executive VP, General Counsel & Secretary
Mr. Ben Sorci	Executive Vice President of Operations
Mr. Pankaj Tiwari	Executive VP & Chief Information Officer
Ms. Jee Hamlyn-Harris	Investor Relations Officer
Mr. Ben Tompkins	Executive Vice President of Development & Compliance
Ms. Shruthi Narayan	Executive VP & GM of Interventional

Important FAQs about investing in Penumbra (PEN) from India :

What is Penumbra share price today?

Penumbra share price today stands at $273.78, Open: $275.65 ; Previous Close: $275.84 ; High: $275.13 ; Low: $270.17 ; 52 Week High: $277.89 ; 52 Week Low: $148.00. The stock opens at $275.65, after a previous close of $275.84. The stock reached a daily high of $275.13 and a low of $270.17, with a 52-week high of $277.89 and a 52-week low of $148.00.

Can Indians buy Penumbra shares?

Yes, Indians can invest in the Penumbra (PEN) from India.

With INDmoney, you can buy Penumbra at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Penumbra at zero transaction cost.

How can I buy Penumbra shares from India?

It is very easy to buy Penumbra from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Penumbra be purchased?

Yes, you can buy fractional shares of Penumbra with INDmoney app.

What are the documents required to start investing in Penumbra stocks?

To start investing in Penumbra, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.